10Feb
The LHD/ERISA Advisor: Sixth Circuit Rejects MSPA and ERISA Discrimination Claims
Seeking to control healthcare costs, many group health plans have adopted amendments that lower reimbursement rates for the treatment of end-stage renal disease ("ESRD"), which requires long-term dialysis treatment or a kidney transplant, resulting...
By:
Hinshaw & Culbertson LLP
Related
In a short published opinion filed September 13, 2019, the First District Court of Appeal (Div. 4) a...
Read More >
This week, Boston Mayor Marty Walsh’s office announced a new protocol for re-starting city construc...
Read More >
The covid-19 pandemic has dramatically altered all aspects of life. The acquisition and leverage fin...
Read More >
In a close 4 to 3 decision, the Ohio Supreme Court has affirmed the constitutionality of a state sta...
Read More >
Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals from TPG ...
Read More >
On Jan. 1, 2020, the California Consumer Privacy Act (CCPA), a consumer-friendly privacy law inspire...
Read More >